Serial Number | 97357986 |
Word Mark | RECEPIOS |
Filing Date | Monday, April 11, 2022 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Wednesday, July 31, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 27, 2023 |
Goods and Services | Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 18, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Vanda Pharmaceuticals Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Washington, DC 20037 |
Party Name | Vanda Pharmaceuticals Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Washington, DC 20037 |
Event Date | Event Description |
Monday, February 6, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, April 14, 2022 | NEW APPLICATION ENTERED |
Monday, April 18, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, January 26, 2023 | ASSIGNED TO EXAMINER |
Monday, February 6, 2023 | NON-FINAL ACTION E-MAILED |
Monday, February 6, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, May 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, May 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, June 7, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 23, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, August 22, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, June 27, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, June 27, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Thursday, February 1, 2024 | SOU TEAS EXTENSION RECEIVED |
Thursday, February 1, 2024 | SOU EXTENSION 1 FILED |
Thursday, February 1, 2024 | SOU EXTENSION 1 GRANTED |
Saturday, February 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, July 31, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, July 31, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, July 31, 2024 | SOU EXTENSION 2 FILED |
Wednesday, July 31, 2024 | SOU EXTENSION 2 GRANTED |